Nevertheless, our current investigation reveals that LSS, a critical enzyme in the latter stages of cholesterol synthesis, is down‐regulated in CRC and BRCA cells and significantly promoted tumor progression and shortened patient survival. The gene discussed is LSS; the disease is colorectal carcinoma.